Developing Web Application for Virtual Screening and Prediction of Breast Cancer Drugs: Target Interaction and Drug Approval Using Machine Learning
Conference proceedings article
ผู้เขียน/บรรณาธิการ
กลุ่มสาขาการวิจัยเชิงกลยุทธ์
รายละเอียดสำหรับงานพิมพ์
รายชื่อผู้แต่ง: Chumsang, Jantharat; Phangsee, Thanaphon; Wiriyaprapanont, Nattaporn; Arromrit, Trirat; Prom-On, Santitham;
Mahikul, Wiriya
ผู้เผยแพร่: Institute of Electrical and Electronics Engineers Inc.
ปีที่เผยแพร่ (ค.ศ.): 2023
หน้าแรก: 196
หน้าสุดท้าย: 201
จำนวนหน้า: 6
ISBN: 9798350333862
ภาษา: English-Great Britain (EN-GB)
บทคัดย่อ
Breast cancer is the most prevalent cancer globally with a high patient mortality rate. As a result, researchers are trying to find new effective drugs to treat the disease. However, drug discovery is costly and time-consuming, making it difficult to succeed. Virtual screening is a tool for drug discovery as it can quickly assess the potential of many drug candidates, reducing time and cost. The study aims to develop a web application for the virtual screening of breast cancer drugs using a machine-learning approach. The data for this study was collected from the ChEMBL database and contained 8 human breast cancer target proteins, including mTOR, Trop-2, PI3K, CDK4/6, HER2, Aromatase, Akt, and Estrogen Receptor. The data is preprocessed with Feature Engineering using Lipinski's rule with the SMILE structure of a compound. The data is also applied in developing machine learning algorithms with two main objectives: predicting Drug-Target interaction and Drug Approvals with a classification model. Results of the study show that the SMILE structure and Lipinski's rule with machine learning are used for the virtual screening of many compounds from new drug discovery. The Gradient boosting Classifier is found to be the most suitable algorithm for predicting drug approval with the geometric mean, F1-score, and AUC of 0.95, 0.96, and 0.98, while the Random Forest Classifier is the best for drug target interactive with accuracy, F-1 score, and AUC of 0.75, 0.74, and 0.80, respectively. Moreover, we deploy machine learning with a web application and reduce time and cost in finding new drugs, increasing the chances of success in finding new treatments to reduce the mortality rate of breast cancer patients. © 2023 IEEE.
คำสำคัญ
Drug discovery
ติดต่อสอบถามเพิ่มเติมได้ที่